News
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...
5h
Zacks Investment Research on MSNLLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III StudyShares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.
21h
Lose It! on MSNCoping With Common Side Effects of GLP-1 MedicationsIf you are taking a weight loss medication such as Ozempic, Wegovy, or Zepbound for obesity or other health concerns, you may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results